Abstract: A new fluorescent method was developed based on the ulifloxacin-europium (ill )-sodium dodecylbenzene sulfonate system for the determination of ulifloxacin, the active metabolite of prulifloxacin. Sodium dodecylbenzene sulfonate formed a ternary complex with ulifloxacin-europium (ill) and significantly enhanced the characteristic fluorescence of europium (ill). The enhanced fluorescence intensity showed a good linear relationship with the concentration of ulifloxacin in the range of 5.0 x 10-8 -2. 0 X 10-6 M with a detection limit of 2.0 x 10-10 M (30). This method is rapid and sensitive, and has been successfully applied to the determination of ulifloxacin in human urine and serum samples. Keywords: ulifloxacin; prulifloxacin; europium; fluorescence; sodium dodecylbenzene sulfonate . After oral administration' and intestinal absorption, PUFX is rapidly metabolized by paraoxonases into UFX, the active metabolite of prulifloxacin [2] [3] [4] [5] [6] [7] . Therefore, the in vitro antimicrobial activity was studied using ulifloxacin [6, 8, 9] . o For the pharmacokinetic study of a prulifloxacin formulation product in healthy volunteers, a rapid, selective and sensitive analytical method is required to accurately determine the ulifloxacin concentration in body fluid. In previous studies, analysis of ulifloxacin has been performed by high performance liquid chromatography ( HPLC) with ultraviolet ( UV) detection [10] [20] , and trovafloxacin [21] . But the sensitivity is not very high as all the detection limits of these methods are over the range of 1. 2 x 10-9 to 4.7 x 10-8 M. However, the europium-sensitized fluorescent determination method described here could provide a much higher sensitivity. The detection limit (3a) could attain 2.0 x 10-10 M. Furthermore, there are few reports about the fluorescence mechanism. Compared with most of other approaches for the determination of UFX, the proposed method offers advantages in higher sensitivity, wider linear range, and better stability, which has been successfully applied to the determination of ulifloxacin in human urine and serum samples with satisfactory results, and the fluorescence enhancement mechanism is also discussed. To our knowledge, this is the first time that the europium-sensitized fluorescent determination is utilized for the determination of UFX.°X~P UFX: R= o==< I o CH 3 UFX:R=H
Chemical structures of ulifloxacin (UFX) and prulifloxacin (PUFX) Prulifloxacin (PUFX, NM441 , Figure 1 ), the prodrug of ulifloxacin (UFX, NM394 , Figure 1 ), is a broad-spectrum oral fluoroquinolone antibacterial agent [1] . After oral administration' and intestinal absorption, PUFX is rapidly metabolized by paraoxonases into UFX, the active metabolite of prulifloxacin [2] [3] [4] [5] [6] [7] . Therefore, the in vitro antimicrobial activity was studied using ulifloxacin [6, 8, 9] . o For the pharmacokinetic study of a prulifloxacin formulation product in healthy volunteers, a rapid, selective and sensitive analytical method is required to accurately determine the ulifloxacin concentration in body fluid. In previous studies, analysis of ulifloxacin has been performed by high performance liquid chromatography ( HPLC) with ultraviolet ( UV) detection [10] , HPLC with fluorescence detection [11] , HPLC-MS/MS [12] , capillary zone electrophoresis [13] , flow-injection chemiluminescence [14] and terbium-sensitized second-order scattering spectrofluorimetry [15] .
Europium-sensitized fluorescent determination is an indirect method involving complexation of ligand molecules and europium ions. The intramolecular energy transfer from the absorbing ligand to the europium ions results in the emission of a strong narrow-band fluorescence with a large Stokes shift and long decay time. As a result, it could avoid the potential background fluorescent interferences from the biological matrix [16] . Quinolones and f1uoroquinolones have suitable functional groups (carboxylic and ketO-oxygen atoms) to form stable complexes with lanthanide ions. This technique has been widely utilized for the determination of quinolones norfloxacin [17] , enoxacin [18] , garenoxacin [19] , ciprofloxacin [20] , and trovafloxacin [21] . But the sensitivity is not very high as all the detection limits of these methods are over the range of 1. 2 x 10-9 to 4.7 x 10-8 M. However, the europium-sensitized fluorescent determination method described here could provide a much higher sensitivity. The detection limit (3a) could attain 2.0 x 10-10 M. Furthermore, there are few reports about the fluorescence mechanism. Compared with most of other approaches for the determination of UFX, the proposed method offers advantages in higher sensitivity, wider linear range, and better stability, which has been successfully applied to the determination of ulifloxacin in human urine and serum samples with satisfactory results, and the fluorescence enhancement mechanism is also discussed. To our knowledge, this is the first time that the europium-sensitized fluorescent determination is utilized for In order to study the interaction between UFX-Eu 3 + and SOBS, the ultraviolet absorption spectra were recorded (Figure 3) , which showed that the absorption peak of UFX-Eu 3 + was at 267 nm. However, the absorbance of UFX-Eu 3 + increased apparently after the addition of the SOBS solution, which was in accordance with the fluorescence enhancement of the excitation spectra in the UFX-Eu 3 + -SOBS system ( Figure 2) . Also, the maximum absorption wavelength underwent a red shift from 267 nm to 273 nm, indicating the formation of a UFX-&r -SOBS ternary complex [22] .
The excitation and emission spectra of UFX 0, 1'), Eu 3 + (2, 2'), UFX-Eu 3 + (3, 3'), and UFX-Eu 3 + -SOBS (4, 4') system are shown in Figure 2 . The excitation spectrum of the UFX-Eu 3 + -SOBS system exhibited a peak at 276 nm, which was selected as the excitation wavelength. From the emission spectra, no characteristic fluorescence of Eu 3 + was observed in the Eu 3 + system (2'), while weak characteristic fluorescence of Eu 3 + was observed in the UFX-Eu 3 + system (3'). Curve 4' is the emission spectrum of UFX-Eu 3 + -SOBS system and strong emission peaks were observed at 594 and 616 nm, corresponding to transitions of the Eu 3 + 50 0 _7F] and 50 0 _7F 2 , respectively. Compared with the UFX-Eu 3 + system, the fluorescence intensity(h) was enhanced about 37-fold by the addition of SOBS. Thereby, 276 nm and 616 nm were chosen as the excitation wavelength and emission wavelength, respectively. centrifuging for 5 min at 1 500 X g [19] . No sample pretreatment was required for urine samples. Further dilution with water was made to ensure that the concentrations of the drug in the sample solutions fall within the linear range of the method.
2 Materials and methods 2.1 ApparaF luorescence intensity was measured on an Hitachi F-2500 fluorescence spectrophotometer (Japan), using a standard 10 mm path-length quartz cell, with 10 nm bandwidths for both the excitation and emission monochromators. Absorption spectra were measured on an UV-2401PC spectrophotometer (Shimadzu, Japan) equipped with 10 mm pathlength quartz cells. The surface tension was measured on a Processor Tensiometer-Kl2 (KRUSS Corp., Germany) with the, precise degree of 0.01 mN/m by the Wilhelmy plate. The pH was measured using a Lei Ci pHs-3C pH-meter (Shanghai, China). Serum samples were centrifuged with a Xiang Yi TDZ4A-WS brachytely desk centrifuge (Changsha, China).
Reagents
A standard stock solution (1. 0 X 10-3 M) of UFX (purity, 100.9%, Department of Pharmacy, Beijing Hospital, China) was prepared by dissolving 0.0349 g of UFX in dilute hydrochloric acid and then diluting to 100 mL with water. The solution was kept at 4'C in the refrigerator and protected from light. Standard working solutions were prepared by diluting the standard stock solution with water.
A solution of europium (III) (Eu 3 + ) (1. 0 x 10-3 M) was prepared by dissolving 0.0176 g EU20.J(purity, 99.99%) in hydrochloric acid solution 0 : 1) and evaporating the solution to near dryness before diluting to 100 mL with water. The solution was kept at 4 ·C. The working solutions were diluted with water.
A sodium dodecylbenzene sulfonate (SOBS) solution (2.0 X 10-3 M) was prepared by dissolving O. 0774 g SOBS (purity, 90.0%) in water and then diluting to 100 mL with water.
A NHtCl-NH 3 • H 2 0 buffer solution (pH 8.6, 0.1 M) was prepared by dissolving 1. 3508 g NHt CI in water to 250 mL and then adjusting pH to 8.6 with NKJ ·HzO. All reagents used were of analytical grade unless otherwise indicated. Redistilled water made in-house was used throughout the study. In order to investigate the effect of micellar media on the fluorescence intensity, various types of surfactants including CTAB (Cetrimonium bromide, cationic) , GA (Arabic gum, non-ionic), OP (Polyoxyethylene nonylphenol ether, non-ionic), l3-CD (l3-cyclodextrin, non-ionic), lriton X-100 (non-ionic), Pluronic F68 (non-ionic), PEG40 (nonionic), SDS (Sodium dodecyl sulfate, anionic), and SDBS (anionic) were studied (Table 1) . It can be seen that there was no significant fluorescence enhancement in the presence of cationic surfactants, non-ionic surfactants or anionic surfactant SDS. However, a significant increase in fluorescence was observed in the presence of anionic surfactant SDBS. The effect of the SDBS concentration on the fluorescence intensity was also investigated ( Figure 6 ). Maximum fluorescence intensity was observed at an SDBS concentration of 1. 0 X 10 -4 M, which was chosen for further experiments. The mechanism of SDBS effect was studied by investigating the changes of surface tension of the fluorescence system with an increase of the SDBS concentration ( Figure 7) . It can be seen that the surface tension first decreased sharply, and then reached equilibrium at the SDBS concentration of 7.0 X 10-5 M, which can be considered as the apparent critical micelle concentration (CMC) of SDBS in this system. Since the SDBS concentration selected for the study (1. 0 X 10-4 M) was well above the CMC, it could be concluded that the formation of micelles had a great impact on the enhancement of the fluorescence intensity of the system. 
Methods

Effects of pH and buffers
The effect of pH on the fluorescence intensity of the system was studied in the range of 5.8 -10. 5. The results indicated that the optimal pH value was in the range of 8.2 -8. 8 (Figure 4) , so pH 8.6 was selected for the recommended procedure. Setting pH at 8.6, the effect of the following buffer solutions on the fluorescence intensity was then examined, including NtLAc-NH 3 ' H 2 0, NaAc-HAc, NtLCl-NH 3 ' HzO, Tris-HCl, and KH 2 PO r NaOH. It was found that UFX-Eu 3 + -SDBS fluorescence system in the NtL Cl-NH 3 • Hz°medium of the concentration O. 01 M gave the highest sensitivity. Therefore, a 0.01 M NtLClNl-lJ .H 2 0 buffer solution of pH 8.6 was chosen for further study. (3a) is 2.0 X 10-10 M. In comparison with other methods reported, the rapid and simple method proposed in this paper offers significantly increased sensitivity (Table 3) .
Recovery assay
The maximum concentration of UFX in the serum is between 1. 0 ,uglmL (2.8 x 10-6 M) and 1. 6 ,uglmL (4.6 X 10-6 M) after a single oral administration of 300, 450 and 600 mg PUFX. In contrast, the concentration of UFX in urine is very high after dosing, and can reach more than 60 ,uglmL (1. 7 x 10-4 M) [8] .
In order to ensure that the concentrations of the drug fall within the linear range of the method, urine samples were Table 2 .
The results indicated that most species except for Cu 2 + and Fe experiments also demonstrated that the fluorescence intensity of the system reached a maximum within 15 min after all the reagents had been added and remained stable for at least 3 h. 
5 Effect of reagent addition sequence and fluorescence stability
The effect of the reagent addition sequence on the fluorescence intensity was studied. The results showed that the addition sequence of Etr , UFX, SOBS, and NIL Cl-NHa . Table 4 
